Accountable care organizations have to work more on engaging physicians in meaningful leadership roles and should focus on learning about patient goals, said James Whitfill, MD, chief medical officer of Scottsdale Health Partners.
Accountable care organizations have to work more on engaging physicians in meaningful leadership roles and should focus on learning about patient goals, said James Whitfill, MD, chief medical officer of Scottsdale Health Partners.
Transcript (modified)
How can ACOs do a good job of engaging their physicians?
So physician engagement, while it’s something that everybody talks about, is actually pretty hard to do. A couple of things that we think that have been helpful for us in terms of achieving meaningful engagement is first having real physician leadership. So not just putting physicians in a place where they have a nominal voice, but in fact where they’re actually leading the organization.
At Scottsdale Health Partners, 90% of all our governance positions are filled by physicians. So they have a meaningful role in driving where the organization goes. And then I think making sure that they understand that this is a very different way of practicing, and this is a hard shift, it’s a hard shift for all of us to move from a fee-for-service world to a fee-for-value world.
So we do a lot of education, not just formal education but by physicians being in leadership roles they themselves have to learn, and sort of incorporate these new concepts of value-based healthcare.
How much do patients understand or know about the fact that they are in an ACO? And to they need to know?
So with our patients I don’t think we spend very much time talking about being in an ACO, but we spend a lot of time trying to figure out what their health goals are. Oftentimes, and this is surprising to us as physicians, patients are focused on their own goals, not my goals. And so if I don’t understand what their goals are, whether they are to be out of pain, or if they’re worried about their rent, or how they’re going to care for their children, those goals get in the way of them being able to focus on their health goals.
So we actually spend a lot time trying to understand what those barriers to care are, meeting the patients where they’re at, and then coming up with plans that first meet their goals and then we can mix in our health goals.
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More